Phase 1 Trials

Drug Development Safety and Efficacy Vaccine Safety Chronic Weight Management Patient Monitoring ADC Clinical Studies Drug Evaluation Vaccine Development Vaccine Trials Oncology Trials DREAMM-9 Trial Drug Mechanism Cancer Treatments Phase 2 Trials Patient Recruitment Animal Models Weight Loss Medications Drug Testing Gene Therapy Trials

7 ARTICLES

last mo.

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Backed by a $650 million up-front payment, the agreement places Pfizer in charge of global development for a 12-program cancer portfolio discovered and advanced by Innovent.

6 ARTICLES

2mo ago

Cellular Intelligence Takes Global Rights to Novo Nordisk’s Parkinson’s Cell Therapy

6 ARTICLES

3mo ago

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

4 ARTICLES

4mo ago

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

8 ARTICLES

7mo ago

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

3 ARTICLES

7mo ago

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

4 ARTICLES

8mo ago

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

6 ARTICLES

11mo ago

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

5 ARTICLES

11mo ago

Engineered Gut Microbe for Kidney Stones Gets Triple Safeguard After Mutation Concerns